Text Size
5 studies found for:    Open Studies | "Impetigo"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo
Condition: Non-bullous Impetigo
Interventions: Drug: LTX-109 1 %;   Drug: LTX-109 2 %;   Drug: Placebo gel
2 Not yet recruiting Citriodiol® and Impetigo
Condition: Impetigo
Intervention: Drug: p-menthane-3,8-diol oil
3 Recruiting Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo
Condition: Impetigo
Interventions: Drug: Experimental: CD07223 1.5 % Topical Gel BID;   Drug: Experimental: CD07223 1.5% Topical Gel TID;   Drug: Placebo Comparator: CD07223 vehicle gel BID;   Drug: Placebo Comparator: CD07223 vehicle gel TID
4 Recruiting Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
Conditions: Impetigo;   Folliculitis;   Secondarily Infected Eczema;   Minor Soft Tissue Infections
Intervention: Drug: Retapamulin (Altabax)
5 Not yet recruiting ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
Condition: Skin Infections, Bacterial
Intervention: Drug: ALTARGO(retapamulin)
To Top

† Indicates status has not been verified in more than two years